Predict your next investment

Nuvaira company logo
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
nuvaira.com

See what CB Insights has to offer

Founded Year

2008

Stage

Series F | Alive

Total Raised

$166.02M

Last Raised

$21.34M | 1 yr ago

About Nuvaira

Nuvaira is a privately held company headquartered in Minneapolis, MN. The company’s proprietary Nuvaira Lung Denervation System addresses airway hyper-responsiveness, a pathophysiologic underpinning of both COPD and asthma, in a procedure called Targeted Lung Denervation (TLD). The Nuvaira Lung Denervation System is under clinical investigation and is not commercially available in the USA, and is CE Mark approved.

Nuvaira Headquarter Location

3750 Annapolis Lane North Suite 105

Minneapolis, Minnesota, 55447,

United States

763-450-2800

Latest Nuvaira News

Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone

Sep 24, 2021

100 Randomized Patients; Inspire’s CEO Tim Herbert appointed Chairman of the Board MINNEAPOLIS, August 11, 2021 – Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, has announced that ... Continued The post Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone appeared first on Windham Venture Partners.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Nuvaira

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nuvaira is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

8,733 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Nuvaira Patents

Nuvaira has filed 53 patents.

The 3 most popular patent topics include:

  • Respiratory therapy
  • Lung disorders
  • Respiratory diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/14/2014

8/31/2021

Calcium channel blockers, Dosage forms, Drug delivery devices, Potassium channel blockers, Respiratory therapy

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/14/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/31/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Calcium channel blockers, Dosage forms, Drug delivery devices, Potassium channel blockers, Respiratory therapy

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Nuvaira Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Nuvaira Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.